Life Sciences

Roche v Menarini (UPC/CFI/712/2025)

Decision date:

01 October 2025

Court
Düsseldorf LD
Patent
EP 1 962 668

Full decision (in German) available here:

Osborne Clarke summary

  • The judge-rapporteur of the Düsseldorf LD made a confidentiality order in accordance with Article 58 UPCA and Rule 262A RoP in infringement proceedings between the parties.
  • The court classified certain details of the manufacturing process of the challenged embodiments of Menarini, information on negotiations between Roche and the manufacturer of the attacked embodiments (Sinocare), pricing and expected profits with respect to the contested embodiments, and certain portions of written witness statements as confidential information.
  • Access was restricted to the Roche's legal representatives, four designated personnel, and witnesses and experts who require access for the purposes of the proceedings.
  • The judge-rapporteur deferred the decision on what will be kept confidential during the oral hearing, the judgment and what should be disclosed to any third parties making a request for access.

This analysis is based on a machine translation of a decision not available in English.

Issue

Procedural
Confidentiality

Curious about how UPC decisions might impact your business? Have questions about the UPC?

Reach out to our patents team for expert guidance and support.